Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 608.06M P/E - EPS this Y -23.50% Ern Qtrly Grth -
Income -63.48M Forward P/E -12.23 EPS next Y 33.30% 50D Avg Chg 9.00%
Sales 21.05M PEG - EPS past 5Y - 200D Avg Chg 25.00%
Dividend N/A Price/Book 1.78 EPS next 5Y - 52W High Chg -50.00%
Recommedations 1.70 Quick Ratio 4.17 Shares Outstanding 117.62M 52W Low Chg 175.00%
Insider Own 5.67% ROA -13.61% Shares Float 95.98M Beta -
Inst Own 74.09% ROE -19.77% Shares Shorted/Prior 5.81M/5.15M Price 5.26
Gross Margin 100.00% Profit Margin - Avg. Volume 609,317 Target Price 9.88
Oper. Margin -593.34% Earnings Date - Volume 640,637 Change -5.05%
About OmniAb, Inc.

OmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic, a bispecific rat, and OmniClic, a bispecific chicken, designed for discovery of bispecific antibody applications; OmniTaur, which provides unique structural characteristics of cow antibodies for complex targets; and OmniDeep, a suite of in silico, an AI and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.

OmniAb, Inc. News
05/15/24 OmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston Summit
05/12/24 OmniAb, Inc. (NASDAQ:OABI) Q1 2024 Earnings Call Transcript
05/11/24 We're Keeping An Eye On OmniAb's (NASDAQ:OABI) Cash Burn Rate
05/11/24 OmniAb First Quarter 2024 Earnings: Misses Expectations
05/09/24 OmniAb Reports First Quarter 2024 Financial Results and Business Highlights
05/01/24 OmniAb to Participate in Five Investor Conferences in May
04/22/24 OmniAb to Report First Quarter 2024 Financial Results on May 9
04/03/24 Insiders Load Up on These 2 Stocks — Here’s Why You Should Follow
03/26/24 OmniAb, Inc. (NASDAQ:OABI) Analysts Are More Bearish Than They Used To Be
03/25/24 OmniAb Inc (OABI) President and CEO Matthew Foehr Acquires 225,000 Shares
03/21/24 OmniAb, Inc. (NASDAQ:OABI) Q4 2023 Earnings Call Transcript
03/21/24 Q4 2023 OmniAb Inc Earnings Call
03/20/24 OmniAb Inc (OABI) Reports Decline in Annual Revenue and Net Loss for Q4 and Full Year 2023
03/20/24 OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
02/28/24 OmniAb, Inc. (OABI) Soars 10.5%: Is Further Upside Left in the Stock?
02/26/24 OmniAb to Report Fourth Quarter 2023 Financial Results on March 20
02/20/24 OmniAb to Participate in Two Investor Conferences in March
01/11/24 With 62% institutional ownership, OmniAb, Inc. (NASDAQ:OABI) is a favorite amongst the big guns
12/15/23 Mighty Minis: 7 Small-Cap Stocks That Punch Above Their Weight
12/15/23 President of OmniAb Matthew Foehr Buys 8.2% More Shares
OABI Chatroom

User Image Stock_Titan Posted - 1 day ago

$OABI OmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston Summit https://www.stocktitan.net/news/OABI/omni-ab-presents-high-throughput-single-b-cell-screening-x-ploration-89u03bb7rqd8.html

User Image Stock_Titan Posted - 1 week ago

$OABI OmniAb Reports First Quarter 2024 Financial Results and Business Highlights https://www.stocktitan.net/news/OABI/omni-ab-reports-first-quarter-2024-financial-results-and-business-0gp9abhdtwv0.html

User Image FHE_wizard Posted - 1 week ago

$OABI BULLISH!!! Next-gen solutions in cell and gene therapy. #BiotechBreakthroughs

User Image Stock_Titan Posted - 2 weeks ago

$OABI OmniAb to Participate in Five Investor Conferences in May https://www.stocktitan.net/news/OABI/omni-ab-to-participate-in-five-investor-conferences-in-06z9tvv2sfwn.html

User Image tranq19 Posted - 04/24/24

$OABI big insider buy just now? Foehr to the rescue again?

User Image Stock_Titan Posted - 04/22/24

$OABI OmniAb to Report First Quarter 2024 Financial Results on May 9 https://www.stocktitan.net/news/OABI/omni-ab-to-report-first-quarter-2024-financial-results-on-may-n4qtpvlpv90w.html

User Image bearsoil Posted - 04/18/24

$OABI stock price drop reflects slower revenue growth than expected Good entry opportunity as long term should have good growth. Insiders and institutions have been holding

User Image insiderbuyingselling Posted - 1 month ago

$OABI new insider selling: 6954 shares. http://insiderbuyingselling.com/?t=OABI

User Image Jtree123 Posted - 1 month ago

$OABI lots of insider buying here!

User Image TipRanks Posted - 1 month ago

Insiders Load Up on These 2 Stocks — Here’s Why You Should Follow https://www.tipranks.com/news/article/insiders-load-up-on-these-2-stocks-heres-why-you-should-follow-2 $FSBC $OABI

User Image Nosh Posted - 03/27/24

$OABI Volatile...but will start an entry here.

User Image InsiderPeek Posted - 03/25/24

$OABI CEO Foehr Matthew W bought 225k shares for $1.2 millions (ownership up 8.38%) insiderpeek.com/company/OABI

User Image CEOBuysDisclosures Posted - 03/25/24

$OABI CEO purchased 225,000 shares at $5.19 for a total of $1,167,750. FOEHR MATTHEW W now owns 2,908,803 shares. https://ceo-buys.com

User Image tranq19 Posted - 03/25/24

$ABCL $OABI Carl hasn’t bought lately, but my boy Foehr can’t get enough. I own both of these and go back and forth with momentum, but all in on OABI for now. Following his lead buying a cool $1.2M Friday, 3rd huge buy for him in the last year or so

User Image insiderbuyingselling Posted - 03/25/24

$OABI new insider buying: 225000 shares. http://insiderbuyingselling.com/?t=OABI

User Image NavalnyTheGreat Posted - 03/22/24

@jarepeo Better than $ACCO, $CVGI, $OABI? Nah

User Image Thestocktraderhubzee Posted - 03/22/24

$OABI Benchmark Reiterates Buy on OmniAb, Maintains $8 Price Target

User Image DonCorleone77 Posted - 03/20/24

$OABI OmniAb sees FY24 operating expense similar to FY23 The company stated: "OmniAb expects operating expense in 2024 to be approximately the same as in 2023, and is now staffed and resourced to leverage the future growth of the business. OmniAb expects its cash use in 2024 to be relatively similar to its cash used in 2023, excluding the $35 million TECVAYLI milestone payment received in 2023. Given the expected progression of the existing partnered pipeline, OmniAb expects its cash use in 2025 to be substantially lower than in 2024. OmniAb's current cash balance and cash from operations are expected to provide sufficient capital to fund operations for the foreseeable future."

User Image DonCorleone77 Posted - 03/20/24

$OABI OmniAb reports Q4 EPS (14c), consensus (15c) Reports Q4 revenue $4.8M, consensus $7.5M. "2023 was a year of significant expansion of OmniAb's partnership base and pipeline programs as we continued to execute against our plan, while key partner programs made significant progress despite last year's sector-related headwinds. Partners exceeded our expectations regarding the number of new programs entering the clinic, with a total of six new entrants last year," said Matt Foehr, Chief Executive Officer of OmniAb. "In addition, we successfully launched two new technologies and expanded our business development function, now with a presence in the U.S., EU and Asia Pacific. We look forward to meaningful advancements in 2024 and in the coming years, as we are now staffed and resourced to efficiently leverage the future growth of the business."

User Image Stock_Titan Posted - 03/20/24

$OABI OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights https://www.stocktitan.net/news/OABI/omni-ab-reports-fourth-quarter-and-full-year-2023-financial-results-erexl884a1kf.html

User Image Tank80 Posted - 2 months ago

$THAR has a license agreement with $OABI with 500M MC. Maybe they should just buy Thar out

User Image johnnyutah007 Posted - 2 months ago

$OABI 💪 here

User Image ChartReaders Posted - 02/27/24

$OABI Different Moving Averages and lower indicator mix, but love the strategy and thoughts!! This is worth eyes for tomorrow!

User Image dojidad Posted - 02/27/24

$OABI I set an alert right over resistance for a possible entry.

User Image johnnyutah007 Posted - 02/27/24

$OABI 💥

User Image JoeDeMencia Posted - 02/27/24

$OABI flying today. what's the news?

User Image Ninja_Tradez Posted - 02/26/24

📢 $OABI - OmniAb to Report Fourth Quarter 2023 Financial Results on March 20 https://newsfilter.io/a/94a01d8668969ce060dd7c1ead756a77

User Image Stock_Titan Posted - 02/26/24

$OABI OmniAb to Report Fourth Quarter 2023 Financial Results on March 20 https://www.stocktitan.net/news/OABI/omni-ab-to-report-fourth-quarter-2023-financial-results-on-march-b6k3azcuwcko.html

User Image Stock_Titan Posted - 02/20/24

$OABI OmniAb to Participate in Two Investor Conferences in March https://www.stocktitan.net/news/OABI/omni-ab-to-participate-in-two-investor-conferences-in-y57tle07vd54.html

User Image johnnyutah007 Posted - 3 months ago

$OABI gaining steam again

Analyst Ratings
Benchmark Buy May 14, 24
Truist Securities Buy Mar 26, 24
Benchmark Buy Mar 22, 24
HC Wainwright & Co. Buy Mar 21, 24
RBC Capital Outperform Mar 21, 24
Benchmark Buy Nov 14, 23
HC Wainwright & Co. Buy Aug 11, 23
Benchmark Buy May 12, 23
Benchmark Buy Apr 21, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
FOEHR MATTHEW W Chief Executive Offi.. Chief Executive Officer Dec 12 Buy 5.05 200,000 1,010,000 2,645,442 12/13/23
FOEHR MATTHEW W President and CEO President and CEO Nov 10 Buy 4.2686 95,000 405,517 2,427,919 11/13/23
FOEHR MATTHEW W President and CEO President and CEO Aug 14 Buy 5.48 45,000 246,600 2,332,919 08/15/23
FOEHR MATTHEW W Chief Executive Offi.. Chief Executive Officer Jun 09 Buy 4.52 115,000 519,800 2,574,009 06/12/23
HIGGINS JOHN L Director Director May 18 Sell 3.89 50,000 194,500 2,462,686 05/19/23
HIGGINS JOHN L Director Director May 18 Option 3.68 50,000 184,000 2,512,686 05/19/23
Cochran Jennifer R. Director Director Dec 06 Buy 3.754 22,250 83,526 77,476 12/08/22
FOEHR MATTHEW W President & CEO President & CEO Nov 30 Buy 3.3878 300,000 1,016,340 1,705,350 12/01/22
GUSTAFSON KURT A EVP, Finance and CFO EVP, Finance and CFO Nov 28 Buy 2.81 10,000 28,100 170,062 11/29/22
Patel Sunil Director Director Nov 09 Buy 2.77 43,000 119,110 215,512 11/10/22
FOEHR MATTHEW W President & CEO President & CEO Nov 09 Buy 2.7616 100,000 276,160 1,405,350 11/09/22